Home / News

Asia: The 3rd Vietnam-Japan Symposium

2022/11/24  PMDA

Globalization of research and development, manufacturing and marketing of medical products has progressed, and cooperation in regulatory activities amongst regulatory agencies has become inevitably important. As the Asian region becomes significant in the area of clinical development and manufacturing of medical products today, PMDA strives to strengthen the collaborative relationship with the Asian regulatory agencies.

This is the joint conference with an aim to enhance Vietnam and Japan’s mutual understanding of regulatory systems to pursue more effective and efficient pharmaceutical regulations.

This symposium will offer presentations with our latest information and discussions from the pharmaceutical regulatory perspective in the area of Actions for COVID-19 by regulatory authorities, Digitalization in drug review system, International collaboration to provide products satisfied with patients’ needs in Asia.


  • Pharmaceuticals and Medical Devices Agency (PMDA)
  • The Drug Administration Department of Vietnam (DAV)


  • 29 Nov, 2022 (Tuesday)


  • The symposium will be held by virtual (Zoom).
  • Participants will receive the link by email.

To continue reading this article please go to PMDA .